National drug rates regulator NPPA on Friday stated it has actually repaired market prices of 23 solutions, consisting of the medications to deal with diabetes and hypertension. The National Pharmaceutical Pricing Authority (NPPA) has actually repaired the costs under the Drugs (Price Control) Order, 2013 based upon the choice of 113th Authority conference dated May 26, 2023.
Based on the alert, the NPPA has actually repaired the rate of one tablet of diabetes drug Gliclazide ER and Metformin Hydrochloride tablets at Rs 10.03.
The retail cost of one tablet of Telmisartan, Chlorthalidone & & Cilnidipine tablets at Rs 13.17. The market price of one tablet of painkiller medication Trypsin, Bromelain, Rutoside Trihydrate and Diclofenac Sodium tablets has actually been repaired at Rs 20.51.
The NPPA stated it has actually likewise modified ceiling rate of 15 arranged formulas under Drugs (Prices Control) Order, 2013 (NLEM 2022).
It has actually likewise repaired ceiling rate of 2 set up formulas.
It has actually repaired and modified ceiling cost of one arranged solution, the alert stated.
The NPPA is mandated to fix/revise the rates of regulated bulk drugs and solutions and to implement costs and accessibility of the medications in the nation. It likewise keeps an eye on the rates of decontrolled drugs in order to keep them at affordable levels.
The regulator carries out and imposes the arrangements of the Drugs (Prices Control) Order.
It is likewise turned over with the job of recuperating quantities overcharged by makers for regulated drugs from customers.
(Catch all business News, Breaking News Events and Latest News Updates on The Economic Times.)
Download The Economic Times News App to get Daily Market Updates & & Live Business News.
